vTv Therapeutics Inc. announced entry into agreements that include a $10 million investment by CinPax, LLC, a subsidiary of CinRx Pharma, LLC. Dr. Jon Isaacsohn, Chief Executive Officer of CinRx, who has been involved in the clinical development of countless therapeutics, is expected to join the vTv Board of Directors.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
29.01 USD | 0.00% | +12.09% | +152.26% |
05-09 | VTv Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-14 | VTv Therapeutics Inc. Announces Board Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+152.26% | 70.58M | |
+11.10% | 115B | |
+12.70% | 106B | |
-4.10% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-11.64% | 17.56B | |
-39.36% | 17.32B | |
+7.41% | 14.03B | |
+32.86% | 12.13B |
- Stock Market
- Equities
- VTVT Stock
- News vTv Therapeutics Inc.
- Jon Isaacsohn to Join the vTv Therapeutics Inc. Board of Directors